AA
AlphaCentric Advisors’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,500
| Closed | -$944K | – | 217 |
|
|
2024
Q3 | $944K | Sell |
10,500
-4,500
| -30% | -$404K | 0.7% | 50 |
|
|
2024
Q2 | $1.21M | Sell |
15,000
-17,500
| -54% | -$1.41M | 0.89% | 37 |
|
|
2024
Q1 | $2.59M | Buy |
+32,500
| New | +$2.59M | 1.56% | 14 |
|
|
2021
Q4 | – | Sell |
-23,000
| Closed | -$758K | – | 224 |
|
|
2021
Q3 | $758K | Buy |
23,000
+11,000
| +92% | +$363K | 0.19% | 47 |
|
|
2021
Q2 | $810K | Buy |
12,000
+2,000
| +20% | +$135K | 0.22% | 36 |
|
|
2021
Q1 | $566K | Buy |
+10,000
| New | +$566K | 0.19% | 40 |
|